Willis Towers Watson Public Limited Company (WTW) Q3 2026 Earnings Call Transcript

Willis Towers Watson Public Limited Company (WTW) Q3 2026 Earnings Call Transcript

Seeking Alpha • 6 hours ago

WTW Reports Third Quarter 2026 Earnings

Revenue1 increased 8% from prior year to $2.5 billion for the quarter Organic Revenue growth of 4% for the quarter Diluted Earnings per Share was $3.24 for the quarter, up 4% over prior year Adjusted Diluted Earnings per Share was $3.63 for the quarter, up 18% over prior year Operating Margin was 17.4% for the quarter, down 90 basis points from prior year Adjusted Operating Margin was 21.9% for the quarter, up 150 basis points from prior year LONDON, Oct. 29, 2026 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW) (the “Company”), a leading global advisory, broking and solutions company, today announced financial results for the third quarter ended September 30, 2026. “WTW delivered another quarter of solid results in the face of a volatile market environment, reflecting the strength and resilience of our business,” said Carl Hess, WTW's Chief Executive Officer.

GlobeNewsWire • 15 hours ago

Willis Towers Watson (WTW) Q3 Earnings Surpass Estimates

Willis Towers Watson (WTW) came out with quarterly earnings of $3.63 per share, beating the Zacks Consensus Estimate of $3.6 per share. This compares to earnings of $3.07 per share a year ago.

Zacks Investment Research • 13 hours ago

WTW Q3 Earnings Beat Estimates on Margin Gains, Revenues Miss

Willis Towers Watson beats Q3 earnings estimates as organic growth, expanding margins and strong cash flow support its 2026 outlook and AI-driven savings plan.

Zacks Investment Research • 9 hours ago

Willis Towers Watson (WTW) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for Willis Towers Watson (WTW) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • 11 hours ago

Willis Towers Watson (WTW) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Get a deeper insight into the potential performance of Willis Towers Watson (WTW) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks Investment Research • Oct 28, 2026

Willis urges mining sector to take advantage of favourable market conditions to improve resilience

LONDON, Oct. 28, 2026 (GLOBE NEWSWIRE) -- The global insurance market for the mining sector remains highly favourable for buyers, with abundant capacity, sustained competition among insurers and continued downward pressure on rates, according to the latest Mining Risk Review 2026 from Willis, a WTW business (NASDAQ: WTW). Demand for critical minerals is accelerating, which has led to robust prices across a range of commodities, prompting miners to invest in new projects, partnerships and technologies. At the same time, they are facing a rapidly evolving risk environment that demands a renewed focus on resilience and long-term risk management.

GlobeNewsWire • Oct 28, 2026

WTW 2026 Best Practices in Healthcare Survey: U.S. employer healthcare costs set to rise at fastest pace in more than two decades

Pharmacy costs climb 11.5% as employer ratings of PBMs plunge; nearly half say significant health plan changes are needed within three years Pharmacy costs climb 11.5% as employer ratings of PBMs plunge; nearly half say significant health plan changes are needed within three years

GlobeNewsWire • Oct 28, 2026

WTW Launches Via Retirement to Drive Wealth Business Growth

Willis Towers Watson launches Via Retirement to expand its wealth business, tapping growing demand for retirement-income solutions and potential advisory and annuity revenue.

Zacks Investment Research • Oct 28, 2026

16% of Employers Are Thinking About Cutting Weight-Loss Drug Coverage

Employers are quietly reconsidering who foots the bill for GLP-1 weight-loss drugs, and the fallout hits Eli Lilly and Novo Nordisk very differently heading into earnings week.

24/7 Wall Street • Oct 28, 2026